1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Elasmogen Ltd.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

Aberdeen UK

Primary Industry

Pharmaceuticals

About

Founded in 2016 and based in Aberdeen, UK, Elasmogen Ltd. is a biopharmaceutical company that develops drugs, sourced from a shark protein called variable new-antigen receptors (VNARS), for treating inflammatory, autoimmune diseases, and cancers.
Current Investors
Deepbridge Capital, Scottish Enterprise, Innovate UK

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.elasmogen.com
Verticals
HealthTech, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo